Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Nuvectis Pharma, Inc. (NVCT)

$19.31 -4.17% NASDAQ: NVCT · 15-min delayed
  • FORT LEE, New Jersey
  • Public · NASDAQ: NVCT
  • 13 employees
$253.1MMarket cap
-$26.4MNet income
13Employees
NVCTNASDAQ
2022IPO

About Nuvectis Pharma, Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$26.4M
Total assets
$31.7M
Market cap
$253.1M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Operating income
-$27.6M
Net income
-$26.4M
EPS (basic)
$-1.32
EPS (diluted)
$-1.32

Balance sheet

Total assets
$31.7M
Current assets
$31.7M
Total liabilities
$13.3M
Current liabilities
$13.3M
Shareholders’ equity
$18.4M

Cash flow

Operating cash flow
-$16.0M
Investing cash flow
-$13.1M
Financing cash flow
$29.1M
Net cash flow
$0

Statements via Polygon.io (SEC filings)

NASDAQ: NVCT
$19.31 -4.17%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$5.65 $28.53

52-week range

Market cap
$253.1M
EPS (diluted)
$-1.32
Shares outstanding
13.1M
Open
Day range
Prev close
Volume
IPO date
Feb 4, 2022

Nuvectis Pharma, Inc. (NVCT) Stock Price

  • Reported a net loss of $26.4M.
  • Trading 32% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Nuvectis Pharma, Inc..

Write a review
Newsroom

News about Nuvectis Pharma, Inc.

News & sentiment via Polygon.io

FAQ

Nuvectis Pharma, Inc.: frequently asked questions

Is Nuvectis Pharma, Inc. an American company?

Nuvectis Pharma, Inc. is a US-based company headquartered in Fort Lee, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Nuvectis Pharma, Inc. headquartered?

Nuvectis Pharma, Inc. is headquartered in Fort Lee, New Jersey, United States.

Is Nuvectis Pharma, Inc. publicly traded?

Yes — Nuvectis Pharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol NVCT on the NASDAQ.

What does Nuvectis Pharma, Inc. do?

Nuvectis Pharma, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →